BioNTech SE Sponsored ADR BNTX
98.52
(0.74)
(0.75%)
as of 25 Sep
- Market cap
- $24.9B
- P/E
- 0.0×
Follow BNTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 27.07 | 3.59 | 5.19 | 509.50 | 0.00 | 0.00 | 0.00 |
P/S ratio |
7.09 | 9.20 | 6.54 | 1.98 | 2.80 | 34.84 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 5.35 | 2.60 | 71.94 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
66.76 | (53.39) | 30.26 | 24.68 | (271.39) | 65.79 | (135.65) | (57.01) | (57.01) |
P/B ratio |
1.06 | 1.30 | 1.23 | 1.71 | 4.47 | 12.25 | 15.73 | 6.61 | 6.61 |
Price to Tangible BV |
1.18 | 1.39 | 1.31 | 1.73 | 4.55 | 13.91 | 20.35 | 8.55 | 8.55 |
EV/Sales |
2.00 | 3.19 | 2.26 | 1.18 | 2.71 | 32.54 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 9.89 | 1.60 | 3.35 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
12.56 | 42.30 | 1.61 | 1.51 | 57.77 | (1,164.83) | 0.00 | 0.00 | 0.00 |
EV/FCF |
(19.85) | (36.10) | 1.85 | 1.55 | 69.54 | (160.68) | 0.00 | 0.00 | 0.00 |
Quick Ratio |
7.40 | 7.25 | 9.12 | 7.19 | 4.15 | 2.50 | 3.86 | 3.42 | 1.15 |
Current Ratio |
7.54 | 7.45 | 9.43 | 7.43 | 4.33 | 2.75 | 4.05 | 3.56 | 1.18 |
Net Debt/EBITDA |
14.29 | 16.26 | (18.69) | (1.09) | (0.12) | 25.35 | 3.05 | 11.22 | 2.42 |
Debt/Assets |
1.22% | 1.13% | 0.95% | 0.91% | 1.90% | 10.36% | 8.85% | 8.30% | 0.00% |
Debt/Equity |
0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.18 | 0.14 | 0.20 | (1.05) |
Asset Turnover |
0.13 | 0.12 | 0.17 | 0.84 | 2.10 | 0.31 | 0.15 | 0.39 | 0.12 |
Operating CF/Net income |
(0.40) | (0.31) | 5.77 | 1.44 | 0.09 | (0.89) | 1.11 | 1.21 | 0.61 |
Capex/Depreciation |
(1.94) | (1.51) | (3.85) | (2.94) | (2.00) | (2.17) | (2.10) | (3.05) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (6.01%) | (3.35%) | 4.68% | 56.47% | 155.73% | 1.64% | (46.21%) | (44.25%) | (79.18%) | |
| (5.22%) | (2.92%) | 4.07% | 45.96% | 113.92% | 0.98% | (24.10%) | (14.71%) | (16.22%) | |
ROIC |
(19.03%) | (28.51%) | 11.02% | 127.38% | 94.38% | (19.47%) | (262.39%) | 0.00% | 0.00% |
Return on Tangible Assets |
(7.53%) | (3.86%) | 5.11% | 48.18% | 86.40% | 1.18% | (34.76%) | (10.94%) | (61.78%) |
Average Days of Receivables |
124.23 | 200.86 | 223.15 | 150.68 | 238.16 | 125.90 | 42.58 | 56.73 | 58.19 |
Research and Development Expense of Revenue |
73.34% | 81.94% | 46.69% | 8.88% | 5.00% | 133.73% | 208.55% | 112.12% | 123.19% |
Selling, General and Administrative Expense of Revenue |
21.76% | 21.77% | 14.60% | 3.14% | 1.77% | 22.51% | 44.45% | 23.03% | 47.83% |
Intangible Assets out of Total Assets |
0.09 | 0.05 | 0.05 | 0.01 | 0.01 | 0.07 | 0.11 | 0.13 | 0.00 |
Share Based Compensation of Revenue |
2.82% | (1.95%) | (18.72%) | 0.33% | 0.42% | 6.66% | 27.84% | 5.99% | 0.00% |
Graham Net Nets |
0.66 | 0.62 | 0.67 | 0.54 | 0.21 | 0.04 | 0.03 | 0.07 | 0.07 |
Graham Number |
0.00 | 0.00 | 92.22 | 284.29 | 253.85 | 4.90 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(5.50%) | (2.62%) | 3.69% | 27.82% | 19.26% | 0.20% | (0.47%) | (1.12%) | (1.12%) |
Free Cash Flow Yield |
(1.42%) | (0.96%) | 18.68% | 38.50% | 1.39% | (0.58%) | 0.00% | 0.00% | 0.00% |
Revenue per Share |
13.43 | 12.38 | 17.18 | 74.96 | 92.01 | 2.34 | 0.58 | 0.79 | 7.67 |
Operating CF per Share |
2.13 | 0.93 | 24.16 | 58.80 | 4.31 | (0.07) | (1.05) | (0.36) | (6.56) |
Capex per Share |
(3.48) | (2.03) | (3.17) | (1.57) | (0.73) | (0.41) | (0.38) | (0.42) | 0.00 |
Free Cash Flow per Share |
(1.35) | (1.10) | 20.99 | 57.23 | 3.58 | (0.47) | (1.43) | (0.78) | (6.56) |
Cash per Share |
69.64 | 75.55 | 74.44 | 60.91 | 10.06 | 6.54 | 2.76 | 2.55 | 23.00 |
Shareholders Equity per Share |
89.99 | 87.37 | 91.07 | 86.85 | 57.67 | 6.66 | 2.61 | 1.65 | (6.56) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
89.99 | 87.37 | 91.07 | 86.85 | 57.67 | 6.66 | 2.61 | 1.65 | (6.56) |
Free Cash Flow |
(326.41) | (263.38) | 5,049.90 | 13,923.01 | 874.43 | (111.58) | (301.95) | (148.01) | (59.00) |
Working Capital |
15,844.46 | 17,616.92 | 18,893.50 | 19,988.27 | 13,712.96 | 1,211.85 | 472.65 | 381.27 | 35.00 |
Capital Expenditures |
(842.33) | (488.14) | (763.56) | (382.14) | (178.17) | (96.19) | (79.59) | (79.30) | (65.00) |
Net Current Asset Value |
15,140.62 | 16,972.63 | 18,146.82 | 19,700.74 | 13,174.06 | 822.60 | 286.72 | 74.37 | (283.00) |
EV/EBIT |
0.00 | 0.00 | 12.52 | 1.62 | 3.36 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.26 | 0.16 | 0.18 | 0.02 | 0.01 | 0.17 | 0.65 | 0.53 | 0.00 |
Net Profit Margin |
(39.59%) | (24.18%) | 24.36% | 54.50% | 54.24% | 3.15% | (164.89%) | (37.64%) | (140.58%) |
Price to Operating Income |
0.00 | 0.00 | 36.18 | 2.72 | 3.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.35 | 0.32 | 0.24 | 0.20 | 0.23 | 0.17 | 0.36 | 0.19 | 0.10 |
Cash ROIC |
(1.82%) | (2.00%) | 12.47% | 37.77% | 3.97% | (8.12%) | (26.88%) | (23.76%) | (86.19%) |
Accounts Receivable Turnover |
2.37 | 1.43 | 0.82 | 1.64 | 3.03 | 5.40 | 6.47 | 8.76 | 3.14 |
Accounts Payable Turnover |
1.36 | 1.39 | 2.17 | 15.61 | 22.50 | 0.97 | 0.54 | 0.29 | 0.40 |
Inventory Turnover |
3.36 | 1.69 | 1.53 | 5.97 | 10.32 | 1.57 | 1.95 | 2.52 | 3.38 |
Average Days of Payables |
304.20 | 287.73 | 215.42 | 24.87 | 20.06 | 629.25 | 430.95 | 1,112.36 | 1,045.23 |
Days of Inventory on Hand |
62.96 | 191.03 | 217.67 | 53.57 | 63.00 | 394.45 | 246.44 | 154.34 | 99.55 |
Average Receivables |
1,371.67 | 2,082.57 | 5,027.99 | 11,089.14 | 7,419.65 | 102.11 | 18.80 | 17.21 | 22.00 |
Average Payables |
533.46 | 422.43 | 299.09 | 202.17 | 153.07 | 69.90 | 36.12 | 56.14 | 55.50 |
Average Inventory |
215.90 | 346.85 | 425.15 | 528.84 | 333.88 | 43.19 | 9.98 | 6.42 | 6.50 |
Average Assets |
24,628.65 | 24,639.56 | 24,713.29 | 21,628.14 | 10,688.99 | 1,770.96 | 832.27 | 385.59 | 598.00 |
Average Common Equity |
21,377.51 | 21,458.45 | 21,521.36 | 17,601.01 | 7,819.25 | 1,059.89 | 434.02 | 128.16 | 122.50 |
Columns are period end dates